AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Inagene Diagnostics Inc. Announces New CEO

May 8, 2019

TORONTO--(BUSINESS WIRE)--May 8, 2019--The Board of Directors of Inagene Diagnostics Inc. is pleased to announce the appointment of Nancy White as its Chief Executive Officer. “We are excited about Nancy’s vision for Inagene,” said Don Wright, Chairman of the Board. “Nancy’s deep expertise in sales and marketing will help Inagene accelerate the commercialization of our organization.” Nancy joined Inagene in January to help develop the sales and marketing strategy. Now that Inagene’s Personal Insights TM test has been successfully launched, Nancy’s deep commercial expertise will help Inagene accelerate sales and business development partnerships.

We are also pleased to announce that Peter Brenders has taken on the role of Strategic Advisor to the Chairman of Inagene. In his new capacity, Peter will play a key role in the company’s next stage of development, supporting the Board and senior management as Inagene grows and plans for expansion. Peter was brought on last year to help set the strategic direction and deliver a commercial launch plan. We have been delighted with the company ’s success in launching not only its first product, but also launching our company.

In the shadow of the opioid crisis, unrelieved pain costs Canadians up to $60 billion yearly in health care expenditures and lost productivity. 1 Many Canadians struggle to find adequate relief. “We are committed to ongoing research and want to make a meaningful difference in the lives of patients suffering from pain.” noted Dr. Katherine Siminovitch, FRCP(C), ABIM, Chief Science Advisor, Inagene Diagnostics Inc.

Inagene’s Personalized Insights TM focuses on providing the most comprehensive genetic test for pain treatments and dependency risk covering 55 genes and 116 variants. Inagene’s own dedicated genetics and research testing lab service is available directly to patients or by recommendation of their healthcare professional. Learn more by visiting our website at inagene.com.

References:

1. Lynch ME. The need for a Canadian pain strategy. Pain Research and Management. 2011;16(2):77-80.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190508005770/en/

CONTACT: For all inquiries contact:

Nancy White

Customer Service

customerservice@inagene.com

KEYWORD: NORTH AMERICA CANADA

INDUSTRY KEYWORD: TECHNOLOGY OTHER TECHNOLOGY HEALTH BIOTECHNOLOGY PHARMACEUTICAL PROFESSIONAL SERVICES HUMAN RESOURCES INSURANCE

SOURCE: Inagene Diagnostics Inc.

Copyright Business Wire 2019.

PUB: 05/08/2019 02:39 PM/DISC: 05/08/2019 02:39 PM

http://www.businesswire.com/news/home/20190508005770/en